Sanfilo Pharma Llp - Company Profile

It is a chemicals limited liability partnership based in Mumbai, Maharashtra, India, established in 2019.
2019 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Sanfilo Pharma Llp

Sanfilo Pharma Llp, a active limited liability partnership, was established on 30 August 2019 in Mumbai, Maharashtra, India. Engaging in chemicals and chemical products within the chemicals sector, it holds LLPIN: AAQ-4232. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Manoj Joshi (Designated Partner), Tejash Upendra Shah (Designated Partner), Sandeep Kumar (Designated Partner). Past directors included Tejash Upendra Shah, Bhavin Rajnikant Desai. Its latest date of accounts and solvency statement 31 March 2023. It is based at Flat 1 Gaurav Sitare Chs Saibaba Nagar Dwarkesh Park Bhd Bhatia School Boriwali, West, Mumbai, Maharashtra, 400092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAQ-4232

  • Incorporation Date

    30 August 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Sanfilo Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sanfilo Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sanfilo Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Manoj Joshi Designated Partner 30 Aug 2019 Current
Tejash Upendra Shah Designated Partner 19 Sep 2019 Current
Sandeep Kumar Designated Partner 30 Aug 2019 Current
Rachana Bhavin Desai Designated Partner 10 Jan 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 18 Sep 2019 Past
Pramod Abcsdd Designated Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanfilo Pharma Llp.

Enhance accessibility to Sanfilo Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sanfilo Pharma Llp revenue growth over time
Sanfilo Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanfilo Pharma Llp?

Unlock access to Sanfilo Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sanfilo Pharma Llp?

Unlock and access historical data on people associated with Sanfilo Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanfilo Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanfilo Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanfilo Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Sanfilo Pharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    The activity Sanfilo Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Rachana Bhavin Desai was appointed as a Designated Partner was appointed as a Designated Partner on 10 Jan 2023 & has been associated with this company since 3 years 19 days . was documented.

  • Director Appointment

    The activity Tejash Upendra Shah was appointed as a Designated Partner was appointed as a Designated Partner on 19 Sep 2019 & has been associated with this company since 6 years 4 months . was completed.

  • Director Appointment

    The activity Manoj Joshi was appointed as a Designated Partner was appointed as a Designated Partner on 30 Aug 2019 & has been associated with this company since 6 years 5 months . was completed.

  • Director Appointment

    Progress on Sandeep Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 30 Aug 2019 & has been associated with this company since 6 years 5 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Sanfilo Pharma Llp?

The LLPIN of Sanfilo Pharma Llp is AAQ-4232.

Where is Sanfilo Pharma Llp headquartered?

Sanfilo Pharma Llp is headquartered at Flat 1 Gaurav Sitare Chs Saibaba Nagar Dwarkesh Park Bhd Bhatia School Boriwali, West, Mumbai, Maharashtra, 400092.

When was Sanfilo Pharma Llp incorporated?

Sanfilo Pharma Llp was incorporated on 30 August 2019.

Who are the current directors of Sanfilo Pharma Llp?

The current directors of Sanfilo Pharma Llp are

What is the primary industry of Sanfilo Pharma Llp?

The primary industry of Sanfilo Pharma Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available